Furthermore, the SKAT-O analysis showed an enrichment of DPP6 rare variants in both AD and FTD patients, with a stronger significance level in FTD (p = 0.006), in which we also identified the PTC variant carriers (0.3%, 2/614). Here, DPP6 is linked to Alzheimer disease.